The Vioxx Settlement
A panel discussion was held about the settlement Merck made with users of its pain reliever Vioxx, which it withdrew from the market in 2004… read more
A panel discussion was held about the settlement Merck made with users of its pain reliever Vioxx, which it withdrew from the market in 2004 because of new studies showing increased cardiovascular risk. Some law professors are arguing that a new and unusual provision in the settlement raises ethical concerns. The panelists discusssed why Merck settled and why the settlement was for so much less than originally anticipated; if the settlement will stand up under legal challenge; comparisons with other settlements; and reform of the system for mass litigation. After the presentations the panelists responded to questions from members of the audience. Mr. Calfee moderated. close
People in this video
-
Theodore "Ted" H. Frank Resident Fellow and Director American Enterprise Institute->Legal Center for the Public Interest
-
Mark Hermann Attorney
-
Richard A. Nagareda Director Vanderbilt University->Branstetter Litigation and Dispute Resolution Program
Hosting Organization
Related Video
-
Comfortably Numb: Open Phones
Charles Barber responded to telephone calls from viewers about his book Comfortably Numb: How Psychiatry Is Medicating a…
-
Deadly Choices
Paul Offit takes a broad look at the anti-vaccine movement in the United States and its consequences for children and ad…
-
Prescription Drug Shortages
President Obama signed an executive order aimed at preventing shortages of prescription drugs. The order broadens report…
-
Deadly Monopolies
Harriet Washington argues that a growing corporate presence in the medical industry yields dire consequences for patient…